[Federal Register Volume 68, Number 231 (Tuesday, December 2, 2003)]
[Notices]
[Page 67478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-29969]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated July 22, 2003, and published in the Federal 
Register on August 5, 2003, (68 FR 46226), Penick, Corporation, 158 
Mount Olivet Avenue, Newark, New Jersey 07114, made application by 
renewal to the Drug Enforcement Administration for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Diphenoxylate (9170).......................  II
Ecgonine (9180)............................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The firm plans to manufacture controlled substances and non-
controlled flavor extracts.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Penick, Corporation to manufacture 
the listed controlled substances is consistent with the public interest 
at this time. DEA has investigated Penick, Corporation to ensure that 
the company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed is granted.

    Dated: November 14, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-29969 Filed 12-1-03; 8:45 am]
BILLING CODE 4410-09-M